Al's Comment:

Exciting results for this experimental treatment which is in clinical trials for recurrent GBM.  This is give  one time, using convection enhanced delivery.  May be worth considering if you have the correct marker: Type II interleukin-4 receptor (consisting of the IL4Rα  and IL13Rα 1)

---

Posted on: 02/10/2019

Medicenna Presents Promising Clinical Data from Phase 2b Recurrent Glioblastoma Trial of MDNA55

 

---

Click HERE to return to brain tumor news headlines.